Propanc Biopharma, Inc. Common Stock Net Asset Quality Index
Propanc Biopharma, Inc. Common Stock net asset quality index. Propanc Biopharma, Inc. Common Stock (PPCB) has a Net Asset Quality Index of 73.6% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $12.78 Million minus total liabilities of $3.38 Million yields net assets of $9.40 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is Propanc Biopharma, Inc. Common Stock's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Propanc Biopharma, Inc. Common Stock (2010–2026)
Net asset quality index of Propanc Biopharma, Inc. Common Stock from 2010 to 2026. This chart shows how Propanc Biopharma, Inc. Common Stock's Net Asset Quality Index has evolved across 17 annual periods from 2010 to 2026. As of June 2026, the index stands at 73.6%, representing net assets of $9.40 Million against total assets of $12.78 Million USD. Check Propanc Biopharma, Inc. Common Stock PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Propanc Biopharma, Inc. Common Stock Net Asset Quality Index by Year (2010–2026)
Propanc Biopharma, Inc. Common Stock net asset quality index by year from 2010 to 2026. The table below presents the year-by-year Net Asset Quality Index for Propanc Biopharma, Inc. Common Stock from 2010 to 2026, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Propanc Biopharma, Inc. Common Stock (PPCB) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 73.6% | $9.40 Million | $12.78 Million | $3.38 Million | ▲ +2.7 pp |
| 2025 | 70.8% | $13.91 Million | $19.63 Million | $5.73 Million | ▲ +5293.1 pp |
| 2024 | -5222.2% | $-3.78 Million | $72.36K | $3.85 Million | ▼ -55.2 pp |
| 2023 | -5167.1% | $-3.12 Million | $60.33K | $3.18 Million | ▼ -1463.9 pp |
| 2022 | -3703.1% | $-3.02 Million | $81.65K | $3.11 Million | ▲ +19711.7 pp |
| 2021 | -23414.8% | $-3.07 Million | $13.10K | $3.08 Million | ▼ -19718.6 pp |
| 2020 | -3696.2% | $-3.64 Million | $98.52K | $3.74 Million | ▲ +535.1 pp |
| 2019 | -4231.3% | $-4.30 Million | $101.65K | $4.40 Million | ▲ +5226.9 pp |
| 2018 | -9458.2% | $-6.75 Million | $71.39K | $6.82 Million | ▼ -3734.2 pp |
| 2017 | -5724.0% | $-5.44 Million | $95.07K | $5.54 Million | ▼ -5047.4 pp |
| 2016 | -676.6% | $-2.57 Million | $379.14K | $2.94 Million | ▼ -189.7 pp |
| 2015 | -487.0% | $-3.05 Million | $627.07K | $3.68 Million | ▲ +751.2 pp |
| 2014 | -1238.1% | $-1.41 Million | $113.75K | $1.52 Million | ▲ +44124.0 pp |
| 2013 | -45362.1% | $-792.48K | $1.75K | $794.22K | ▼ -44199.5 pp |
| 2012 | -1162.6% | $-537.92K | $46.27K | $584.19K | ▼ -1259.8 pp |
| 2011 | 97.2% | $10.51 Million | $10.81 Million | $306.85K | ▲ +523.3 pp |
| 2010 | -426.1% | $-186.90K | $43.86K | $230.76K | — |